TY - JOUR AU - Bosetti, C. AU - Turati, F. AU - Vecchia, C. PY - 2014 DA - 2014// TI - Hepatocellular carcinoma epidemiology JO - Best Pract Res Clin Gastroenterol VL - 28 UR - https://doi.org/10.1016/j.bpg.2014.08.007 DO - 10.1016/j.bpg.2014.08.007 ID - Bosetti2014 ER - TY - JOUR AU - Bosch, F. X. AU - Ribes, J. AU - Diaz, M. PY - 2004 DA - 2004// TI - Primary liver cancer: worldwide incidence and trends JO - Gastroenterology VL - 127 UR - https://doi.org/10.1053/j.gastro.2004.09.011 DO - 10.1053/j.gastro.2004.09.011 ID - Bosch2004 ER - TY - JOUR AU - Sakata, J. AU - Shirai, Y. AU - Wakai, T. PY - 2008 DA - 2008// TI - Preoperative predictors of vascular invasion in hepatocellular carcinoma JO - Eur J Surg Oncol VL - 34 UR - https://doi.org/10.1016/j.ejso.2008.01.031 DO - 10.1016/j.ejso.2008.01.031 ID - Sakata2008 ER - TY - JOUR AU - Uchino, K. AU - Tateishi, R. AU - Shiina, S. PY - 2011 DA - 2011// TI - Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors JO - Cancer VL - 117 UR - https://doi.org/10.1002/cncr.25960 DO - 10.1002/cncr.25960 ID - Uchino2011 ER - TY - JOUR AU - Forner, A. AU - Llovet, J. M. AU - Bruix, J. PY - 2012 DA - 2012// TI - Hepatocellular carcinoma JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(11)61347-0 DO - 10.1016/S0140-6736(11)61347-0 ID - Forner2012 ER - TY - JOUR AU - Llovet, J. M. AU - Ricci, S. AU - Mazzaferro, V. PY - 2008 DA - 2008// TI - Sorafenib in advanced hepatocellular carcinoma JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0708857 DO - 10.1056/NEJMoa0708857 ID - Llovet2008 ER - TY - JOUR AU - Cheng, A. L. AU - Kang, Y. K. AU - Chen, Z. PY - 2009 DA - 2009// TI - Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(08)70285-7 DO - 10.1016/S1470-2045(08)70285-7 ID - Cheng2009 ER - TY - JOUR PY - 2015 DA - 2015// TI - Korea practice guideline for the management of Hepatocellular carcinoma JO - Gut Liver VL - 9 ID - ref8 ER - TY - JOUR AU - Park, H. C. AU - Yu, J. I. AU - Cheng, J. C. PY - 2016 DA - 2016// TI - Consensus for radiotherapy in Hepatocellular carcinoma from the 5th Asia-Pacific primary liver cancer expert meeting (APPLE 2014): current practice and future clinical trials JO - Liver Cancer VL - 5 UR - https://doi.org/10.1159/000367766 DO - 10.1159/000367766 ID - Park2016 ER - TY - JOUR AU - Lee, I. J. AU - Seong, J. PY - 2011 DA - 2011// TI - Radiotherapeutic strategies in the management of hepatocellular carcinoma JO - Oncology VL - 81 UR - https://doi.org/10.1159/000333275 DO - 10.1159/000333275 ID - Lee2011 ER - TY - JOUR AU - Han, K. H. AU - Seong, J. AU - Kim, J. K. PY - 2008 DA - 2008// TI - Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis JO - Cancer VL - 113 UR - https://doi.org/10.1002/cncr.23684 DO - 10.1002/cncr.23684 ID - Han2008 ER - TY - JOUR AU - Toyoda, H. AU - Nakano, S. AU - Kumada, T. PY - 1995 DA - 1995// TI - The efficacy of continuous local arterial infusion of 5-fluorouracil and Cisplatin through an implanted reservoir for severe advanced Hepatocellular carcinoma JO - Oncology VL - 52 UR - https://doi.org/10.1159/000227477 DO - 10.1159/000227477 ID - Toyoda1995 ER - TY - JOUR AU - Ando, E. AU - Tanaka, M. AU - Yamashita, F. PY - 2002 DA - 2002// TI - Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases JO - Cancer VL - 95 UR - https://doi.org/10.1002/cncr.10694 DO - 10.1002/cncr.10694 ID - Ando2002 ER - TY - JOUR AU - Itamoto, T. AU - Nakahara, H. AU - Tashiro, H. PY - 2002 DA - 2002// TI - Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein JO - J Surg Oncol VL - 80 UR - https://doi.org/10.1002/jso.10116 DO - 10.1002/jso.10116 ID - Itamoto2002 ER - TY - JOUR AU - Yamada, R. AU - Sato, M. AU - Kawabata, M. PY - 1983 DA - 1983// TI - Hepatic artery embolization in 120 patients with unresectable hepatoma JO - Radiology VL - 148 UR - https://doi.org/10.1148/radiology.148.2.6306721 DO - 10.1148/radiology.148.2.6306721 ID - Yamada1983 ER - TY - STD TI - Kothary N, Weintraub JL, Susman J, et al. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol. 2007;18(12):1517–26. ID - ref16 ER - TY - JOUR AU - Kiely, J. M. AU - Rilling, W. S. AU - Touzios, J. G. PY - 2006 DA - 2006// TI - Chemoembolization in patients at high risk: results and complications JO - J Vasc Interv Radiol VL - 17 UR - https://doi.org/10.1097/01.RVI.0000195074.43474.2F DO - 10.1097/01.RVI.0000195074.43474.2F ID - Kiely2006 ER - TY - JOUR AU - Georgiades, C. S. AU - Hong, K. AU - D'Angelo, M. PY - 2005 DA - 2005// TI - Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis JO - J Vasc Interv Radiol VL - 16 UR - https://doi.org/10.1097/01.RVI.0000182185.47500.7A DO - 10.1097/01.RVI.0000182185.47500.7A ID - Georgiades2005 ER - TY - JOUR AU - Lee, I. J. AU - Kim, J. W. AU - Han, K. H. PY - 2014 DA - 2014// TI - Concurrent chemoradiotherapy shows long-term survival after conversion from locally advanced to resectable hepatocellular carcinoma JO - Yonsei Med J VL - 55 UR - https://doi.org/10.3349/ymj.2014.55.6.1489 DO - 10.3349/ymj.2014.55.6.1489 ID - Lee2014 ER - TY - JOUR AU - Lee, I. J. AU - Seong, J. AU - Shim, S. J. PY - 2009 DA - 2009// TI - Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy JO - Int J Radiat Oncol Biol Phys VL - 73 UR - https://doi.org/10.1016/j.ijrobp.2008.04.035 DO - 10.1016/j.ijrobp.2008.04.035 ID - Lee2009 ER - TY - JOUR AU - Lencioni, R. AU - Llovet, J. M. PY - 2010 DA - 2010// TI - Modified RECIST (mRECIST) assessment for hepatocellular carcinoma JO - Semin Liver Dis VL - 30 UR - https://doi.org/10.1055/s-0030-1247132 DO - 10.1055/s-0030-1247132 ID - Lencioni2010 ER - TY - JOUR AU - Cha, H. AU - Yoon, H. I. AU - Lee, I. J. PY - 2013 DA - 2013// TI - Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma JO - J Radiat Res VL - 54 UR - https://doi.org/10.1093/jrr/rrt034 DO - 10.1093/jrr/rrt034 ID - Cha2013 ER - TY - JOUR AU - Yoon, H. I. AU - Song, K. J. AU - Lee, I. J. PY - 2016 DA - 2016// TI - Clinical benefit of hepatic arterial infusion concurrent Chemoradiotherapy in locally advanced Hepatocellular carcinoma: a propensity score matching analysis JO - Cancer Res Treat VL - 48 UR - https://doi.org/10.4143/crt.2014.276 DO - 10.4143/crt.2014.276 ID - Yoon2016 ER - TY - JOUR AU - Han, D. H. AU - Joo, D. J. AU - Kim, M. S. PY - 2016 DA - 2016// TI - Living donor liver transplantation for advanced Hepatocellular carcinoma with portal vein tumor thrombosis after concurrent Chemoradiation therapy JO - Yonsei Med J VL - 57 UR - https://doi.org/10.3349/ymj.2016.57.5.1276 DO - 10.3349/ymj.2016.57.5.1276 ID - Han2016 ER - TY - JOUR AU - Vogl, T. J. AU - Nour-Eldin, N. E. AU - Emad-Eldin, S. PY - 2011 DA - 2011// TI - Portal vein thrombosis and arterioportal shunts: effects on tumor response after chemoembolization of hepatocellular carcinoma JO - World J Gastroenterol VL - 17 UR - https://doi.org/10.3748/wjg.v17.i10.1267 DO - 10.3748/wjg.v17.i10.1267 ID - Vogl2011 ER - TY - JOUR AU - Yamamoto, K. AU - Imamura, H. AU - Matsuyama, Y. PY - 2010 DA - 2010// TI - AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC JO - J Gastroenterol VL - 45 UR - https://doi.org/10.1007/s00535-010-0278-5 DO - 10.1007/s00535-010-0278-5 ID - Yamamoto2010 ER - TY - JOUR AU - Bertino, G. AU - Ardiri, A. M. AU - Calvagno, G. S. PY - 2010 DA - 2010// TI - Prognostic and diagnostic value of des-gamma-carboxy prothrombin in liver cancer JO - Drug News Perspect VL - 23 ID - Bertino2010 ER - TY - JOUR AU - Kim, B. K. AU - Ahn, S. H. AU - Seong, J. S. PY - 2011 DA - 2011// TI - Early alpha-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma JO - Liver Int VL - 31 UR - https://doi.org/10.1111/j.1478-3231.2010.02368.x DO - 10.1111/j.1478-3231.2010.02368.x ID - Kim2011 ER -